These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE). Lieberman JA Arch Gen Psychiatry; 2006 Oct; 63(10):1069-72. PubMed ID: 17015808 [No Abstract] [Full Text] [Related]
4. Generic replacement of clozapine: a simple decision model from a Canadian perspective. Layton S; Barbeau M Curr Med Res Opin; 2004 Apr; 20(4):453-9. PubMed ID: 15119982 [TBL] [Abstract][Full Text] [Related]
8. Each of the following statements about the newer medications for schizophrenia, risperidone (risperidol) and clozapine (clozaril), is true, except: Patients receiving risperidone are at risk for agranulocytosis. Can Fam Physician; 1995 Oct; 41():1678, 1680. PubMed ID: 8829578 [No Abstract] [Full Text] [Related]
9. Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK. Duggan A; Warner J; Knapp M; Kerwin R Br J Psychiatry; 2003 Jun; 182():505-8. PubMed ID: 12777341 [TBL] [Abstract][Full Text] [Related]
11. Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis. Oh PI; Iskedjian M; Addis A; Lanctôt K; Einarson TR Can J Clin Pharmacol; 2001; 8(4):199-206. PubMed ID: 11743592 [TBL] [Abstract][Full Text] [Related]
12. Refractory schizophrenia: what works pharmacologically? Sousa S J Psychosoc Nurs Ment Health Serv; 1999 Feb; 37(2):19-23. PubMed ID: 10023603 [TBL] [Abstract][Full Text] [Related]
13. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center]. Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P Encephale; 1998; 24(4):365-77. PubMed ID: 9809242 [TBL] [Abstract][Full Text] [Related]
14. The Business Case for Expanded Clozapine Utilization. Gören JL; Rose AJ; Smith EG; Ney JP Psychiatr Serv; 2016 Nov; 67(11):1197-1205. PubMed ID: 27301766 [TBL] [Abstract][Full Text] [Related]
16. Health status and health care costs for publicly funded patients with schizophrenia started on clozapine. Blieden N; Flinders S; Hawkins K; Reid M; Alphs LD; Arfken CL Psychiatr Serv; 1998 Dec; 49(12):1590-3. PubMed ID: 9856622 [TBL] [Abstract][Full Text] [Related]
18. A dilemma born of progress: switching from clozapine to a newer antipsychotic. Rafal S; Tsuang MT; Carpenter WT Am J Psychiatry; 1999 Jul; 156(7):1086-90. PubMed ID: 10401457 [No Abstract] [Full Text] [Related]
19. Cost-effectiveness of clozapine therapy for severe psychosis. Ghaemi SN; Ziegler DM; Peachey TJ; Goodwin FK Psychiatr Serv; 1998 Jun; 49(6):829-31. PubMed ID: 9634167 [TBL] [Abstract][Full Text] [Related]
20. Predictors of Clozapine Funding in Southwestern Ontario. Pallaveshi L; Mak M; Rudnick A Psychiatr Serv; 2016 Jan; 67(1):143-4. PubMed ID: 26725498 [No Abstract] [Full Text] [Related] [Next] [New Search]